Effect of Socheongryong-tang and Yeongyopaedok-san in Upper Respiratory Tract Infection
ESYUI
1 other identifier
interventional
480
0 countries
N/A
Brief Summary
The purpose of this study is to determine whether Socheongryong-tang (SCRT) and Yeongyopaedok-san (YPS) are effective in the treatment of upper respiratory tract infection.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for phase_3
Started Sep 2008
Shorter than P25 for phase_3
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2008
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2009
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2009
CompletedFirst Submitted
Initial submission to the registry
November 23, 2009
CompletedFirst Posted
Study publicly available on registry
November 25, 2009
CompletedApril 6, 2012
April 1, 2012
9 months
November 23, 2009
April 4, 2012
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Changes of score daily measured by WURSS-K before, during and after treatment
daily (7 days)
Secondary Outcomes (2)
Time of symptom disappearance
daily
Changes of score daily measured by WURSS-K before, during and after treatment in pattern identification
daily (7days)
Study Arms (3)
Placebo
EXPERIMENTALPlacebo (encapsulated starch + lactose)
SCRT(Socheongryong-tang )
EXPERIMENTALencapsulated Socheongryong-tang extract
YPS (Yeongyopaedok-san)
EXPERIMENTALEncapsulated Yeongyopaedok-san extract
Interventions
Eligibility Criteria
You may qualify if:
- \~60 years old
- Clinical diagnosis of common cold
- Occurring no longer than 48 hours before enrollment
- Presented with runny nose, sore throat, plugged nose, scratchy throat, cough, hoarseness, headache, muscle ache (runny nose, sore throat and at least 1 of others or 1 of runny nose, sore throat and at least 3 of others)
You may not qualify if:
- Allergic rhinitis, asthma, COPD, sinusitis (2 and more recurrence per year), septal deviation, anatomical otitis media, exudative pharyngitis
- Received antihistamines, NSAIDs, corticosteroids, antibiotics, decongestants
- Hepatic cancer, liver cirrhosis, renal failure, congestive heart failure
- Pregnant or lactation
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
YangChun Park, Ph. D.
Daejeon University
Study Design
- Study Type
- interventional
- Phase
- phase 3
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER GOV
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
November 23, 2009
First Posted
November 25, 2009
Study Start
September 1, 2008
Primary Completion
June 1, 2009
Study Completion
July 1, 2009
Last Updated
April 6, 2012
Record last verified: 2012-04